Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.11779/843
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Amin, Alpesh | - |
dc.contributor.author | Keshishian, A | - |
dc.contributor.author | Xie, L | - |
dc.contributor.author | Başer, Onur | - |
dc.contributor.author | Price, K | - |
dc.contributor.author | Lien Vo | - |
dc.contributor.author | Mardekian, J | - |
dc.contributor.author | Mendoza, M | - |
dc.contributor.author | Singhal, S | - |
dc.contributor.author | Patel, C | - |
dc.contributor.author | Odell, K | - |
dc.contributor.author | Trocio J. | - |
dc.date.accessioned | 2019-02-28T13:04:26Z | - |
dc.date.accessioned | 2019-02-28T11:08:26Z | - |
dc.date.available | 2019-02-28T13:04:26Z | - |
dc.date.available | 2019-02-28T11:08:26Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | Amin A, Keshishian A, Xie L, Baser O, Price K, Vo L, Mardekian J, Mendoza M, Singhal S, Patel C, Odell K, Trocio J. (April 2-4, 2016). Real-world comparison of major bleeding risk among untreated non-valvular atrial fibrillation patients and those initiating apixaban, dabigatran, rivaroxaban, or warfarin. American College of Cardiology (ACC) 65th Annual Scientific Session & Expo. San Diego, CA. | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.11779/843 | - |
dc.description | Onur Başer (MEF Author) | en_US |
dc.description.abstract | Background: Recent large randomized controlled trials have shown that novel oral anticoagulants (NOACs) are at least as effective as warfarin for risk reduction of stroke in patients with non-valvular atrial fibrillation (NVAF) and are associated with similar or lower rates of bleeding. The study aim was to compare major bleeding risk among untreated NVAF patients to those initiating apixaban, dabigatran, rivaroxaban or warfarin | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | American College of Cardiology (ACC) 65th Annual Scientific Session & Expo | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Real-World Comparison of Major Bleeding Risk Among Untreated Non-Valvular Atrial Fibrillation Patients and Those Initiating Apixaban, Dabigatran, Rivaroxaban, or Warfarin | en_US |
dc.type | Conference Object | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.department | İİSBF, Ekonomi Bölümü | en_US |
dc.institutionauthor | Başer, Onur | - |
item.grantfulltext | embargo_20890211 | - |
item.fulltext | With Fulltext | - |
item.languageiso639-1 | en | - |
item.openairetype | Conference Object | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
Appears in Collections: | Ekonomi Bölümü Koleksiyonu |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Real.pdf Until 2089-02-11 | Konferans Dosyası | 400.87 kB | Adobe PDF | View/Open Request a copy |
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.